September 29: The Week in Cancer News
Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.
Progress Against Cancer
Cancer drug shortages affect pediatric care, and ‘power dynamics’ limit women’s access to cancer care globally.
Approvals issued in July, August, and September 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new bispecific T-cell engagers for multiple myeloma, a special kit to treat liver metastases from uveal melanoma, and more.
Based on estimates from the National Cancer Institute, in 2023, more than 110,000 cases of gynecologic cancers are expected to be diagnosed in the U.S., and approximately 34,000 people will die from these diseases. ...
Study links proper dental hygiene to increased survival in head and neck cancer, and researchers use breast milk to detect breast cancer in new mothers.
In combination with stem cell transplant, vaccination-induced immune response and was associated with long-term control of the disease. Cancer scientists have developed a vaccine that may improve the response to therapy in patients with...
New report charts progress in cancer care, and immediate access to test results can lead to confusion.
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
Research shows an increase in late-stage prostate cancer diagnosis, and many non-English speakers don’t make it past helplines to access services.
As you say farewell to summer, say hello to the latest installment of Editors’ Picks selected by the editors of the 10 AACR journals. This month’s selections include a drug that can help overcome...
Regulators reverse course on a plan to limit compensation for breast reconstruction surgery, and more news selected by the editors of Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now